Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Structured Yoga: Participants enrolled in structured Yoga group will be engaged for a total duration of 12 weeks undergoing 15mins of structured yoga thrice weekly.
Intervention2: Struc
Sponsors
American Society of Clinical Oncology (ASCO)
Eligibility
Inclusion criteria
Inclusion criteria: 1) Histologically confirmed hormone-receptor positive breast cancer (Stage I III). 2) Planned to start ET (tamoxifen, ovarian function suppression, or aromatase inhibitors). 3) ECOG performance status 0-2. 4) Ability to perform yoga exercises as per physician s discretion
Exclusion criteria
Exclusion criteria: 1) Pre-existing moderate to severe vasomotor symptoms before ET initiation. 2) Medical conditions limiting participation in yoga (e.g., severe osteoarthritis, interstitial lung disease, cardiac failure).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Endpoint: 1. Proportion of patients experiencing moderate to severe hot flashes within 12 weeks of intervention Timepoint: Assessed at baseline, 6, 12, and 24 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Endpoints: 1. Quality of Life (QoL) 2. ET AdherenceTimepoint: Secondary Endpoints: 1. Quality of Life (QoL): Assessed using EORTC QLQ-C30 at baseline, 6, 12, & 24 weeks. 2. ET Adherence: Measured by patient-reported adherence diaries & dose density calculation at baseline, 6, 12, & 24 weeks. | — |
Countries
India
Contacts
Public ContactAtul Batra
All India Institute of Medical Science, New Delhi
Outcome results
None listed